1
|
Paetow G, Logue C, TenBrink W, Zarzar R, Driehorst M, Brown L, Jensen A, Omodt S, Hart D. In-situ simulation for the detection of latent risk threats in a hyperbaric medicine department. Undersea Hyperb Med 2020; 47:211-216. [PMID: 32574437 DOI: 10.22462/04.06.2020.6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
Simulation (SIM) can be used in the quality improvement process to discover latent risk threats (LRTs) by running in-situ simulation cases in the clinical environment. We utilized this methodology in the hyperbaric chamber to run six in-situ SIM sessions between February 2017 and January 2019. The debriefing portion of each SIM was used to discuss and document all discovered LRTs. These safety threats were aggregated and categorized, resulting in a total of 22 unique LRTs. LRTs included problems or challenges with equipment, team education, policy/processes, communications, and medications. At a three-month follow-up, the hyperbaric leadership team had addressed each of the 22 unique LRTs. SIM can be used to identify, categorize and prioritize LRTs in an effective manner, in order to improve the health care delivery system in a hyperbaric medicine department.
Collapse
Affiliation(s)
- Glenn Paetow
- Hennepin Healthcare, Interdisciplinary Simulation & Education Center, Minneapolis, Minnesota U.S
| | - Chris Logue
- Hennepin Healthcare, Interdisciplinary Simulation & Education Center, Minneapolis, Minnesota U.S
| | - William TenBrink
- Hennepin Healthcare, Interdisciplinary Simulation & Education Center, Minneapolis, Minnesota U.S
| | - Rochelle Zarzar
- Hennepin Healthcare, Interdisciplinary Simulation & Education Center, Minneapolis, Minnesota U.S
| | - Mindi Driehorst
- Hennepin Healthcare, Interdisciplinary Simulation & Education Center, Minneapolis, Minnesota U.S
| | - Lisa Brown
- Hennepin Healthcare, Interdisciplinary Simulation & Education Center, Minneapolis, Minnesota U.S
| | - Andrea Jensen
- Hennepin Healthcare, Department of Hyperbaric Medicine, Minneapolis, Minnesota U.S
| | - Steven Omodt
- Hennepin Healthcare, Department of Hyperbaric Medicine, Minneapolis, Minnesota U.S
| | - Daniell Hart
- Hennepin Healthcare, Department of Hyperbaric Medicine, Minneapolis, Minnesota U.S
| |
Collapse
|
2
|
Churchill S, Deru K, Weaver LK, Wilson SH, Hebert D, Miller RS, Lindblad AS. Adverse events and blinding in two randomized trials of hyperbaric oxygen for persistent post-concussive symptoms. Undersea Hyperb Med 2019; 46:331-340. [PMID: 31394602] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
Safety monitoring and successful blinding are important features of randomized, blinded clinical trials. We report chamber- and protocol-related adverse events (AEs) for participants enrolled in two randomized, double-blind clinical trials of hyperbaric oxygen (HBO2) for persistent post-concussive symptoms clinicaltrials.gov identifiers NCT01306968, HOPPS, and NCT01611194, BIMA), as well as the success of maintaining the blind with a low-pressure sham control arm. In both studies, participants were randomized to receive HBO2 (1.5 atmospheres absolute, >99% oxygen) or sham chamber sessions (1.2 atmospheres absolute, room air). In 143 participants undergoing 4,245 chamber sessions, chamber-related adverse events were rare (1.1% in the HOPPS study, 2.2% in the BIMA study). Minor, non-limiting barotrauma was the most frequently reported. Rarely, some participants experienced headache with chamber sessions. No serious adverse events were associated with chamber sessions. An allocation questionnaire completed after intervention revealed that the sham control arm adequately protected the blind in both trials. Participants based allocation assumptions on symptom improvement or lack of symptom improvement and could not discern intervention arm by pressure, smell, taste, or gas flow.
Collapse
Affiliation(s)
- Susan Churchill
- Division of Hyperbaric Medicine, Intermountain Medical Center, Murray, Utah and Intermountain LDS Hospital, Salt Lake City, Utah U.S
| | - Kayla Deru
- Division of Hyperbaric Medicine, Intermountain Medical Center, Murray, Utah and Intermountain LDS Hospital, Salt Lake City, Utah U.S
| | - Lindell K Weaver
- Division of Hyperbaric Medicine, Intermountain Medical Center, Murray, Utah and Intermountain LDS Hospital, Salt Lake City, Utah U.S
- Department of Medicine, University of Utah School of Medicine, Salt Lake City, Utah U.S
| | | | | | | | | |
Collapse
|
3
|
Liu Y, Feng L, Jia XB. [Explore and analyze influence factors of quality control on traditional Chinese medicine preparation]. Zhongguo Zhong Yao Za Zhi 2017; 42:1808-1813. [PMID: 29082712 DOI: 10.19540/j.cnki.cjcmm.20170228.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Received: 01/14/2017] [Indexed: 06/07/2023]
Abstract
Chinese medicine preparations are dosage forms made from Chinese herbs as raw materials for medical treatment or prevention. From the active pharmaceutical ingredients to the finished products, every link can affect the quality of Chinese medicine preparations. In recent years, reports about adverse reactions of traditional Chinese medicine preparations have been increasing, so their quality and security problems are increasingly prominent. To solve these problems, the authors in this paper would elucidate the necessity and urgency of quality control from the various influence factors of the Chinese medicine preparations by analyzing how these factors affect the quality, and this could provide the reference for developing the "safe, effective and controllable" modernized Chinese medicine.
Collapse
Affiliation(s)
- Ying Liu
- School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China
- Key Laboratory of New Drug Delivery System of Chinese Meteria Medica, Jiangsu Provincial Academy of Chinese Medicine, Nanjing 210028, China
| | - Liang Feng
- Key Laboratory of New Drug Delivery System of Chinese Meteria Medica, Jiangsu Provincial Academy of Chinese Medicine, Nanjing 210028, China
| | - Xiao-Bin Jia
- School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China
- Key Laboratory of New Drug Delivery System of Chinese Meteria Medica, Jiangsu Provincial Academy of Chinese Medicine, Nanjing 210028, China
| |
Collapse
|
4
|
Jiang JJ, Xie YM, Zhang Y, Yang ZX, Yi DH. [32 546 intensive hospital monitoring cases of Shuxuetong injection]. Zhongguo Zhong Yao Za Zhi 2016; 41:3852-3858. [PMID: 28929666 DOI: 10.4268/cjcmm20162023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/07/2016] [Indexed: 06/07/2023]
Abstract
This study adopted multi-center and large sample design to understand the incidence, characteristics and other information about adverse reaction of Shuxuetong injection. In 54 medical institutions, use of Shuxuetong injection of entire treatment period was monitored, including patients' general information, diagnostic information, medication, adverse reaction/event information, etc. Sixty four cases of adverse reactions in 32 546 patients was monitored, adverse rate was 0.197%, mainly characterized by skin itching, rash, flu-like, dyspnea, palpitations, headache, chest tightness and other allergic reactions. Adverse reaction occurred mainly in elderly patients and medication was consistent with the instruction. Based on these results, safety of Shuxuetong injection in clinical application is excellent.
Collapse
Affiliation(s)
- Jun-Jie Jiang
- Institute of Basic Medical Sciences, Chinese Academy of Traditional Chinese Medicine, Beijing 100700, China
| | - Yan-Ming Xie
- Institute of Basic Medical Sciences, Chinese Academy of Traditional Chinese Medicine, Beijing 100700, China
| | - Yin Zhang
- Institute of Basic Medical Sciences, Chinese Academy of Traditional Chinese Medicine, Beijing 100700, China
| | - Zhi-Xin Yang
- College of Statistics, Renmin University of China, Beijing 100872, China
| | - Dan-Hui Yi
- College of Statistics, Renmin University of China, Beijing 100872, China
| |
Collapse
|
5
|
Yang LY, Liu XS, Xiao W, Wang ZZ. [Adverse reactions and countermeasures of drugs for children in China]. Zhongguo Zhong Yao Za Zhi 2016; 41:2743-2747. [PMID: 28905615 DOI: 10.4268/cjcmm20161428] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/20/2016] [Indexed: 06/07/2023]
Abstract
In recent years, the clinical medication safety for children has gained wide public concern. Because of the growth and development characteristics of the children and drug usage conditions for children, the adverse reactions of drugs in clinic are more common in children than those in adults. In this paper, the common adverse drug reactions and their causes would be briefly introduced, and some suggestions would be put forward on how to reduce the incidence of adverse drug reactions.
Collapse
Affiliation(s)
- Lin-Yong Yang
- Jiangsu Kanion Modern Chinese Medicine Institute, Lianyungang 222047, China
- State Key Laboratory of Pharmaceutical New-tech for Chinese Medicine, Lianyungang 222047, China
- Beijing University of Chinese Medicine, School of Management, Beijing 100029, China
| | - Xin-She Liu
- Beijing University of Chinese Medicine, School of Management, Beijing 100029, China
| | - Wei Xiao
- Jiangsu Kanion Modern Chinese Medicine Institute, Lianyungang 222047, China
- State Key Laboratory of Pharmaceutical New-tech for Chinese Medicine, Lianyungang 222047, China
| | - Zhen-Zhong Wang
- Jiangsu Kanion Modern Chinese Medicine Institute, Lianyungang 222047, China
- State Key Laboratory of Pharmaceutical New-tech for Chinese Medicine, Lianyungang 222047, China
| |
Collapse
|
6
|
Wang JD, Xie YM, Liao X, Cui RZ. [Systematic review on safety of Xinyuan capsules]. Zhongguo Zhong Yao Za Zhi 2016; 41:1744-53. [PMID: 28891628 DOI: 10.4268/cjcmm20160928] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/20/2015] [Indexed: 11/17/2022]
Abstract
To systematically review the adverse drug reactions/adverse events(ADRs/AEs) of Xinyuan capsules in clinical application. A systematic literature search was performed in the databases of the Cochrane Library, Medline, EMBASE, the Web of Science, Clinical trials, CNKI, VIP, WanFang Data and CBM. The literature was screened and data was extracted according to the inclusion and exclusion criteria. Because of the substantial heterogeneity among different studies, we assessed them only with descriptive analysis by study type, disease diagnosis, and ADRs/AEs conditions. All included studies were assessed by using the internationally recognized report quality evaluation standard or methodological quality assessment tools. A total of 42 studies involving 3 671 patients were included finally. Two thouand four hundred and thirty-mine patients of them took Xinyuan capsules, and 1 242 patients did not take Xinyuan capsules. No serious ADRs occurred in all patients. One patient died as AE during the research. Sixteen patients of the 2 439 patients taking Xinyuan capsules (alone or in combination) had ADRs, including 7 patients with polytherapy of Xinyuan capsules and 9 patients with monotherapy. The most common ADRs were in gastrointestinal tract, mainly including thirst, nausea, vomiting and abdominal pain, etc. The ADRs included 10 gastrointestinal tract ADRs, 3 renal ADRs and 1 ADR respective in skin system, respiratory system and cardiovascular system. Xinyuan capsules was generally safe in clinical application. The reports on the study of Xinyuan capsules were dispersed in various clinical studies, the study on drug safety still should be strengthened in the future. Further mechanism studies or clinical observation studies of the drug safety shall be conducted to better guide clinical application in the future.
Collapse
|
7
|
Wang YG, Jin R, Kong XW, Zhang B. [ Safety grade of application of traditional Chinese medicines during pregnancy]. Zhongguo Zhong Yao Za Zhi 2016; 41:150-3. [PMID: 28845658 DOI: 10.4268/cjcmm20160129] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/16/2015] [Indexed: 11/17/2022]
Abstract
The efficacy and safety of application of traditional Chinese medicines (TCMs) during the pregnancy is a hotspot among scholars. However, the traditional pregnancy contraindication content has certain historical limitations, and cannot meet the needs of the current pregnant women for rational drug use. We need to refine and interpret it with modern medical science. In this paper, we summarized the ancient and modern knowledge about pregnancy contradiction and tried to establish a grading safety system, based on the actual clinical practices and thte medication grading concept of western medicines. Specifically speaking, in this paper, we compared the connotations of forbidden/contradiction and cautious use, and focused on the safe herbs that included in the prescriptions for dietary therapy. Meanwhile, in this paper, we summarized the core content of the famous theories of ″You Gu Wu Yun (pregnancy disease)″ and ″Shuai Qi Da Ban Er Zhi (therapy during pregnancy)″, and studied the dangerous and unknown risk of TCMs during pregnancy. At last, a five-grade safety system of TCMs applied on the pregnant women was established, including forbidden, contraindicated, cautious, uncertain and available medicines. We classified medicines with the embryotoxicity (e.g. teratogenic, mutagenic, ageneisa), the traditional toxicity (e.g. abortion), the fierce herbal property (e.g. removing blood stasis, promoting Qi circulation) and reliable edible medicinal herbs. We also place an ″uncertain″ category based on objective reality. Meanwhile, 33 sample TCMs were preliminarily determined. This paper proposed the preference and ideas for the rational herbal use in pregnancy.
Collapse
|
8
|
Wang YG, Jin R, Qiang SS, Lin ZJ, Li HY, Lu S, Kong XW. [Construction and practice on rational medication model of Chinese patent medicine for orthopedics based on ″symdrome-dosage-toxicity differentiation″ theory]. Zhongguo Zhong Yao Za Zhi 2016; 41:350-353. [PMID: 28861985 DOI: 10.4268/cjcmm20160230] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/14/2015] [Indexed: 06/07/2023]
Abstract
Chinese patent medicines for orthopedics are among the hotspot and difficulty in the rational medication of traditional Chinese medicine (TCM), because they mostly contain toxic medicinal herbs and oriented to special patients. According to the hospital pharmacy practices and the therapeutic theories of TCM, this paper focused on a novel model of rational drug use of Chinese patent medicine for orthopedics based on the principles of ″syndrome-dosage-toxicity differentiation″. We also proposed relevant specifications for guiding their clinical use. Firstly, we proposed a list of the primary clinical application characteristics for rational drug use of orthopedic TCMs, including the syndromes of patient, the dosage of medicine and the toxic ingredients in medicine. Secondly, a database was established for recording the package inserts of all of the 81 orthopedic patent medicines in our hospital, and 2 000 retrospective recipes were analyzed for looking for the high-frequency medicines and common irrational factors. Then clinical case reports involving the adverse reactions and side effects of related drugs were searched from CNKI, VIP and WanFang databases. Then the key information for rational application of each medicine was extracted from these resources and some survey questionnaires. Finally, we established a guide named instructions for clinical use of orthopedic Chinese patient medicines (ICUOCPM) after the discusstion with experts. According to the effect after the practice in hospital for 2 months, the proposed principles of ″syndrome-dosage-toxicity differentiation″ in this paper were believed to be the core elements and the most important clinical monitoring points in TCM for orthopedic patents. It would provide innovative ideas, theoretical guarantee and data support for the development of TCM clinical pharmacy.
Collapse
Affiliation(s)
- Yu-Guang Wang
- Department of Pharmacy, the Third Affiliated Hospital of Beijing University of Chinese Medicine, Beijing 100029, China
| | - Rui Jin
- Department of Pharmacy, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China
| | - Si-Si Qiang
- Department of Pharmacy, the Third Affiliated Hospital of Beijing University of Chinese Medicine, Beijing 100029, China
| | - Zhi-Jian Lin
- School of Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China
| | - Hong-Yan Li
- Department of Pharmacy, the Third Affiliated Hospital of Beijing University of Chinese Medicine, Beijing 100029, China
| | - Shu Lu
- Department of Pharmacy, the Third Affiliated Hospital of Beijing University of Chinese Medicine, Beijing 100029, China
| | - Xiang-Wen Kong
- Department of Pharmacy, the Third Affiliated Hospital of Beijing University of Chinese Medicine, Beijing 100029, China
| |
Collapse
|
9
|
He FY, He H, Zhou YQ, Deng KW, Wang ZQ, Yang YT, Tang Y. [Impact of ″imprinting templates″ characteristics of traditional Chinese medicine injection supramolecules on (anaphylactoid) hypersensibility]. Zhongguo Zhong Yao Za Zhi 2016; 41:345-349. [PMID: 28861984 DOI: 10.4268/cjcmm20160229] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/30/2015] [Indexed: 06/07/2023]
Abstract
The (anaphylactoid) hypersensibility mechanism of ″imprinting templates″ characteristics of traditional Chinese medicine (TCM) injection supramolecules was clarified to lay the foundation to build safety evaluation method. Based on the previous publication on special impact of Chinese medicine theories on supramolcular chemistry, combined with the natural origination of (anaphylactoid) hypersensitized special rules as well as the sensitization phenomenon of cordate houttuynia injection, the impact of the structure characteristics of ″imprinting templates″ in TCM injection supramolecules on its (anaphylactoid) hypersensibility was clarified. In Chinese medicine injections, the supramolecular structures can independently be generated, showing overall apparent (anaphylactoid) hypersensibility nature, and their structure characteristics were dependent on the strength. In addition, (anaphylactoid) hypersensitive critical supramolecular structure was present. When it was administrated by ″injection″, it's structure was not easy to be destroyed, often showing apparent immunogenicity, whereas if it was administrated by ″oral″, the structure would be destroyed by the gastrointestinal tract, showing weaker or no apparent immunogenicity. Therefore, there are differences in (anaphylactoid) hypersensibility between ″injection″ and ″oral″ administration of TCM. TCM injections would produce the supramolecules between ″molecular society″ by independent reaction of supramolecular ″imprinting template″ (chemical determinants), showing apparent immune process of recognition, copying, and storage. Single molecule is a special example for this. The screening of anaphylactoid (sensitinogen) includes the single ingredients and their forming supramolecules for TCM injection. This is the unique feature for safety evaluation of Chinese medicine injection.
Collapse
Affiliation(s)
- Fu-Yuan He
- Department of Pharmaceutics, Hunan University of Chinese Medicine, Changsha 410208, China
- Property and Pharmacodaynamic Key Laboratory of Traditional Chinese Materia Medica, State Administration of Chinese Medicine, Changsha 410208, China
- Processing and Preparation Supramolecular Technologic Laboratory of Traditional Chinese Materia Medica, Hunan University of Chinese Medicine, Changsha 410208, China
- Supramolecular Mechanism and Mathematic-Physics Chracterization for Chinese Materia Medica, Hunan University of Chinese Medicine, Changsha 410208, China
| | - Hong He
- Department of Pharmaceutics, Hunan University of Chinese Medicine, Changsha 410208, China
- Processing and Preparation Supramolecular Technologic Laboratory of Traditional Chinese Materia Medica, Hunan University of Chinese Medicine, Changsha 410208, China
| | - Yi-Qun Zhou
- Department of Pharmaceutics, Hunan University of Chinese Medicine, Changsha 410208, China
- Property and Pharmacodaynamic Key Laboratory of Traditional Chinese Materia Medica, State Administration of Chinese Medicine, Changsha 410208, China
- Processing and Preparation Supramolecular Technologic Laboratory of Traditional Chinese Materia Medica, Hunan University of Chinese Medicine, Changsha 410208, China
| | - Kai-Wen Deng
- The First Affinity Hospital , Hunan University of Chinese Medicine, Changsha 410007, China
| | - Zhi-Qi Wang
- Department of Pharmaceutics, Hunan University of Chinese Medicine, Changsha 410208, China
- Property and Pharmacodaynamic Key Laboratory of Traditional Chinese Materia Medica, State Administration of Chinese Medicine, Changsha 410208, China
| | - Yan-Tao Yang
- Department of Pharmaceutics, Hunan University of Chinese Medicine, Changsha 410208, China
- Property and Pharmacodaynamic Key Laboratory of Traditional Chinese Materia Medica, State Administration of Chinese Medicine, Changsha 410208, China
- Supramolecular Mechanism and Mathematic-Physics Chracterization for Chinese Materia Medica, Hunan University of Chinese Medicine, Changsha 410208, China
| | - Yu Tang
- Department of Pharmaceutics, Hunan University of Chinese Medicine, Changsha 410208, China
- Property and Pharmacodaynamic Key Laboratory of Traditional Chinese Materia Medica, State Administration of Chinese Medicine, Changsha 410208, China
- Supramolecular Mechanism and Mathematic-Physics Chracterization for Chinese Materia Medica, Hunan University of Chinese Medicine, Changsha 410208, China
| |
Collapse
|